HomeProductsBuilding BlocksFunctional GroupsEstersSodium Oxybate
Chemical structure of CAS 502-85-2

Sodium Oxybate

CAS No.502-85-2
MDL No.N/A
MFC4H7NaO3
MW126.09
InChI KeyXYGBKMMCQDZQOZ-UHFFFAOYSA-M
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.502-85-2
Product NameSodium Oxybate

Biological Targets

GABBR1·GABBR2

Associated Conditions

eating disorder·narcolepsy·Pain·Tremor·alternating hemiplegia of childhood·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo.

Drug metabolism and disposition: the biological fate of chemicals • Vol. 35, Issue 2 • 2007
PMID: 17108059DOI: 10.1124/dmd.106.012369

GABAB1 receptor subunit isoforms exert a differential influence on baseline but not GABAB receptor agonist-induced changes in mice.

The Journal of pharmacology and experimental therapeutics • Vol. 319, Issue 3 • 2006
PMID: 16990508DOI: 10.1124/jpet.106.111971

gamma-Hydroxybutyrate induces cyclic AMP-responsive element-binding protein phosphorylation in mouse hippocampus: an involvement of GABA(B) receptors and cAMP-dependent protein kinase activation.

Neuroscience • Vol. 141, Issue 1 • 2006
PMID: 16675135DOI: 10.1016/j.neuroscience.2006.03.056

Sodium oxybate for cataplexy.

The Annals of pharmacotherapy • Vol. 40, Issue 3 • 2006
PMID: 16507620DOI: 10.1345/aph.1G456

Documentation

Similar Products